cytarabine has been researched along with Cystadenocarcinoma, Serous in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baker, TR; Driscoll, D; Piver, MS; Recio, FO | 1 |
1 other study(ies) available for cytarabine and Cystadenocarcinoma, Serous
Article | Year |
---|---|
Evaluation of survival after second-line intraperitoneal cisplatin-based chemotherapy for advanced ovarian cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Clinical Protocols; Cystadenocarcinoma, Serous; Cytarabine; Evaluation Studies as Topic; Female; Follow-Up Studies; Humans; Injections, Intraperitoneal; Laparotomy; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Prospective Studies; Remission Induction; Reoperation; Survival Rate | 1994 |